Your browser doesn't support javascript.
loading
Impact of previous gestational diabetes management on perinatal outcomes in subsequent pregnancies affected by gestational diabetes mellitus.
Klein, Dahlia; Berezowsky, Alexandra; Melamed, Nir; Barret, Jon; Ray, Joel; Persaud, Mira; Murray-Davis, Beth; McDonald, Sarah D; Geary, Michael P; Berger, Howard; Ashwal, Eran.
Afiliação
  • Klein D; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Berezowsky A; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Melamed N; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Barret J; Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, McMaster University Medical Center, McMaster University, Hamilton, Ontario, Canada.
  • Ray J; Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Persaud M; Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.
  • Murray-Davis B; McMaster Midwifery Research Centre, McMaster University Medical Center, McMaster University, Hamilton, Ontario, Canada.
  • McDonald SD; Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, McMaster University Medical Center, McMaster University, Hamilton, Ontario, Canada.
  • Geary MP; Radiology & Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
  • Berger H; Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland.
  • Ashwal E; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Article em En | MEDLINE | ID: mdl-38972010
ABSTRACT

OBJECTIVE:

To determine the impact of prior gestational diabetes mellitus (GDM) on perinatal outcomes in a subsequent GDM pregnancy.

METHODS:

This retrospective cohort study included 544 multiparous patients with two consecutive pregnancies between 2012-2019, where the second (index) pregnancy was affected by GDM. The primary exposure was prior GDM diagnosis, categorized into medical and dietary management. The primary outcome was a composite including need for pharmacotherapy, large-for-gestational age, or neonatal hypoglycemia. Adjusted odds ratios (aOR) were calculated using multivariable logistic regression controlling for maternal age, pre-pregnancy body mass index, and gestational age at GDM diagnosis in the index pregnancy.

RESULTS:

Of the 544 patients, 164 (30.1%) had prior GDM. Prior GDM significantly increased the likelihood of composite outcome compared to no prior GDM (74.4% vs. 57.4%; P < 0.001). After adjusting for confounders, prior GDM remained significantly associated with the composite outcome (aOR 2.03, 95% confidence interval [CI] 1.31-3.15). Stratifying by prior GDM treatment modality, a significant association was found for prior pharmacotherapy-controlled GDM (aOR 3.29, 95% CI 1.64-6.59), but not for prior diet-controlled GDM (aOR = 1.54, 95% CI 0.92-2.60).

CONCLUSION:

A history of pharmacotherapy-controlled GDM in a previous pregnancy increases odds of adverse perinatal outcomes in a subsequent GDM pregnancy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Gynaecol Obstet Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Gynaecol Obstet Ano de publicação: 2024 Tipo de documento: Article